Skip to main content
Premium Trial:

Request an Annual Quote

Genset Announces Complete Sequencing of Two Bacteria Genomes

Premium

PARIS--Genset here announced that it has completely sequenced the genomes of two pathogens, Chlamydia pneumoniae, a possible agent for atherosclerosis lesions, and the Chlamydia trachomatis L2 strain. The company said it is applying for patents for both sequences and that it will license out the therapeutic, diagnostic, and vaccine applications of the genomic data to pharmaceutical companies.

The two bacteria infect a large number of eukaryotic cells and are responsible for a wide range of human diseases. "The determination and analysis of the complete sequence of this important pathogen is a clear demonstration of the power and quality of Genset's fully integrated genome analysis platform," claimed Pascal Brandys, Genset's chairman and CEO, about Chlamydia pneumoniae. He added that the sequencing work reinforces Genset's position in cardiovascular genomics research.

Filed under

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.